BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Mallinckrodt
UBS
Teva
Daiichi Sankyo
Merck
Chubb
Farmers Insurance
Cerilliant
Boehringer Ingelheim

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072945

« Back to Dashboard

NDA 072945 describes CYTARABINE, which is a drug marketed by Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Mylan Pharms Inc, Sagent Pharms, Teva Parenteral, and West-ward Pharms Int, and is included in fourteen NDAs. It is available from five suppliers. Additional details are available on the CYTARABINE profile page.

The generic ingredient in CYTARABINE is cytarabine. There are fifteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the cytarabine profile page.
Summary for 072945
Tradename:CYTARABINE
Applicant:Hospira
Ingredient:cytarabine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 072945
Medical Subject Heading (MeSH) Categories for 072945
Suppliers and Packaging for NDA: 072945
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYTARABINE cytarabine INJECTABLE;INJECTION 072945 ANDA Hospira, Inc. 61703-304 61703-304-36 1 VIAL, MULTI-DOSE in 1 CARTON (61703-304-36) > 25 mL in 1 VIAL, MULTI-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength20MG/ML
Approval Date:Feb 28, 1994TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Baxter
Cantor Fitzgerald
Medtronic
Harvard Business School
Fish and Richardson
UBS
Julphar
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot